As indicated in the latest market research report published by IMARC Group, titled "India Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2025-2033," this report provides an in-depth analysis of the India anti-obesity drugs market share, featuring insights into the India Anti-Obesity Drugs market. It encompasses competitor and regional analyses, as well as recent advancements in the market.
Market Size & Future Growth Potential:
The India anti-obesity drugs market size reached USD 80.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 190.0 Million by 2033, exhibiting a growth rate (CAGR) of 9.9% during 2025-2033.
Note: “We are currently updating our reports to the 2026–2034 period. If you need the latest data, information, and industry insights, please click on “Request Free Sample Report”
Recent News and Developments:
- Eli Lilly's Market Entry (July 2024): Eli Lilly obtained approvals for importing and distributing tirzepatide-based weight-loss medications Zepbound and Mounjaro in India, marking a significant milestone in the country's anti-obesity drug landscape.
- Biosimilar Launch by Glenmark (2024): Glenmark Pharmaceuticals launched Lirafit, a biosimilar version of liraglutide, making GLP-1 receptor agonist therapy more accessible and affordable for Indian patients.
- Government Production Incentives: India announced plans to offer production-linked incentives (PLI) for local manufacturing of GLP-1 drugs targeting diabetes and obesity by 2026, aiming to reduce import dependency and increase affordability.
- Novo Nordisk's Semaglutide Launch: The company launched semaglutide for obesity treatment in India, expanding treatment options for patients who have struggled with traditional weight management approaches.
- Market Inflection Point Recognition: Industry experts have identified 2024 as a pivotal year for obesity medication markets globally, with increasing recognition of obesity as a treatable medical condition requiring pharmaceutical intervention.
- Digital Health Integration: Online pharmacy platforms and telemedicine services are increasingly incorporating anti-obesity medications into their offerings, improving accessibility for patients across different geographical regions.
Request Free Sample Report: https://www.imarcgroup.com/india-anti-obesity-drugs-market/requestsample
India Anti-Obesity Drugs Market Trends:
The India Anti-Obesity Drugs Market is experiencing significant momentum as rising awareness about weight management and lifestyle-related disorders encourages more individuals to seek medical support for obesity. One of the most prominent trends shaping the sector is the growing adoption of prescription-based weight-loss medications supported by clinical research and doctor recommendations. Moreover, newer drug formulations designed to regulate appetite, improve metabolic efficiency, and support long-term weight reduction are gaining popularity among patients seeking sustained results. Additionally, the increasing prevalence of sedentary lifestyles and high-calorie diets is driving demand for drugs paired with structured nutrition plans and personalized fitness programs.
In addition, consumers are showing interest in combination therapies that integrate medical treatment with behavioral counseling and digital health monitoring. Teleconsultation platforms and online pharmacies are further influencing purchase behavior by offering accessible consultations and discreet medication delivery. Furthermore, rising social acceptance of obesity as a medical condition—not just a cosmetic concern—is encouraging more people to pursue evidence-based treatments. Together, these emerging trends underscore a market evolving toward safer, clinically validated, and holistic obesity management solutions in India.
Market Scope and Growth Factors:
The India Anti-Obesity Drugs Market continues to grow strongly due to increasing obesity rates, rising lifestyle diseases, and growing preference for medically supervised weight-loss treatments. The surge in conditions such as diabetes, hypertension, and cardiovascular disorders—often linked to excess weight—is prompting patients and physicians to consider anti-obesity medications as part of comprehensive treatment plans. Moreover, improved access to healthcare facilities, rising disposable incomes, and growing penetration of health insurance are making such treatments more accessible across urban and semi-urban regions. Additionally, government campaigns promoting fitness and nutrition awareness are enabling early identification and intervention for obesity.
In addition, pharmaceutical advancements—such as safer drug formulations, reduced side effects, and improved dosing convenience—are driving higher adoption among patients. The expansion of digital health platforms, offering follow-up consultations, weight tracking tools, and treatment reminders, is also improving long-term compliance. Furthermore, partnerships between pharmaceutical companies, nutritionists, and wellness clinics are strengthening the ecosystem supporting obesity care. Together, these growth drivers ensure that the India Anti-Obesity Drugs Market remains on a strong upward trajectory—supported by medical innovation, rising health consciousness, and India’s growing commitment to combating obesity through structured, evidence-based solutions.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/india-anti-obesity-drugs-market
Comprehensive Market Report Highlights & Segmentation Analysis:
The market report offers a comprehensive analysis of the segments, highlighting those with the largest India Anti-Obesity Drugs Market Share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.
Segmentation by Drug Class:
- Peripherally Acting Drugs
- Centrally Acting Drugs
Segmentation by Drug Type:
- Prescription Drugs
- OTC Drugs
Segmentation by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Segmentation by Regional:
- North India
- South India
- East India
- West India
Competitor Landscape:
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
Key highlights of the Report:
- Historical Market Performance
- Future Market Projections
- Impact of COVID-19 on Market Dynamics
- Industry Competitive Analysis (Porter's Five Forces)
- Market Dynamics and Growth Drivers
- SWOT Analysis (Strengths, Weaknesses, Opportunities, Threats)
- Market Ecosystem and Value Creation Framework
- Competitive Positioning and Benchmarking Strategies
Major Advantages of the Report:
- This report provides market leaders and new entrants with accurate revenue estimates for the overall market and its key subsegments.
- Stakeholders can leverage this report to gain a deeper understanding of the competitive landscape, enabling them to strategically position their businesses and develop effective go-to-market strategies.
- The report provides stakeholders with valuable insights into the market dynamics, offering a comprehensive analysis of key drivers, restraints, challenges, and opportunities.
Why Choose IMARC Group:
- Extensive Industry Expertise
- Robust Research Methodology
- Insightful Data-Driven Analysis
- Precise Forecasting Capabilities
- Established Track Record of Success
- Reach with an Extensive Network
- Tailored Solutions to Meet Client Needs
- Commitment to Strong Client Relationships and Focus
- Timely Project Delivery
- Cost-Effective Service Options
Note: Should you require specific information not included in the current report, we are pleased to offer customization options to meet your needs.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: +1-201971-6302 | Africa and Europe: +44-702-409-7331